Antibe Therapeutics Inc (ATE.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2023 | 03-2022 | 03-2021 | 03-2020 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 0 | 99 | 478 | 572 | 416 |
| Accounts receivable | 443 | 287 | -2,403 | -36 | -422 |
| Accounts payable and accrued liabilities | -217 | 927 | N/A | N/A | N/A |
| Other Working Capital | 28 | 2,502 | 19,659 | 1,691 | 2,226 |
| Other Operating Activity | -16,559 | -20,735 | -17,839 | -14,162 | -9,277 |
| Operating Cash Flow | $-16,305 | $-16,920 | $-105 | $-11,935 | $-7,056 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | -9 | N/A | 0 | -157 |
| Net Acquisitions | 319 | -236 | N/A | N/A | N/A |
| Purchase Of Investment | -48,436 | -19,975 | N/A | N/A | -100 |
| Sale Of Investment | 36,299 | N/A | N/A | 100 | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -2 | N/A |
| Other Investing Activity | 0 | 0 | -264 | 0 | 0 |
| Investing Cash Flow | $-11,827 | $-20,220 | $-264 | $98 | $-257 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 0 | N/A | 4 | -1,291 |
| Debt Issued | N/A | N/A | N/A | 0 | 1,966 |
| Debt Repayment | -79 | -152 | -2,410 | -192 | N/A |
| Common Stock Issued | N/A | 0 | 69,115 | 8,050 | 5,929 |
| Other Financing Activity | 159 | 126 | -545 | 4,141 | 2,983 |
| Financing Cash Flow | $80 | $-26 | $66,160 | $12,003 | $9,587 |
| Exchange Rate Effect | N/A | N/A | N/A | 23 | -7 |
| Beginning Cash Position | 34,807 | 71,973 | 6,182 | 5,993 | 3,726 |
| End Cash Position | 6,755 | 34,807 | 71,973 | 6,182 | 5,993 |
| Net Cash Flow | $-28,052 | $-37,166 | $65,791 | $166 | $2,274 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,305 | -16,920 | -105 | -11,935 | -7,056 |
| Capital Expenditure | -9 | -9 | N/A | -2 | -157 |
| Free Cash Flow | -16,314 | -16,929 | -105 | -11,937 | -7,213 |